Basics Vaxart, Inc IPO Date: December 31, 1981 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.17 | 4.82% Avg Daily Range (30 D): $0.01 | 3.42% Avg Daily Range (90 D): $0.02 | 6.07% Institutional Daily Volume Avg Daily Volume: 4.4M Avg Daily Volume (30 D): .4M Avg Daily Volume (90 D): 1.65M Trade Size Avg Trade Size (Sh.): 280 Avg Trade Size (Sh.) (30 D): 1,190 Avg Trade Size (Sh.) (90 D): 862 Institutional Trades Total Inst.Trades: 1,120 Avg Inst. Trade: $1.61M Avg Inst. Trade (30 D): $.66M Avg Inst. Trade (90 D): $.99M Avg Inst. Trade Volume: .28M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.86M Avg Closing Trade (30 D): $1.31M Avg Closing Trade (90 D): $1.31M Avg Closing Volume: 388.98K     News Oct 8, 2025 @ 12:00 PM Vaxart to Showcase its Norovirus and COVID-19 Oral... Source: Vaxart, Inc. Sep 10, 2025 @ 1:00 PM Concerned Vaxart Stockholders Condemn Boardâ€â„... Source: Concerned Vaxart Stockholders Sep 8, 2025 @ 12:00 PM Vaxart Announces Adjournment of Special Meeting of... Source: Matt Steinberg Aug 29, 2025 @ 12:00 PM Vaxart Granted Extension by Nasdaq to Regain Compl... Source: Vaxart, Inc. Jul 8, 2025 @ 11:00 AM OTC Markets Group Welcomes Vaxart, Inc. to OTCQX Source: Otc Markets Group Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.07 $-.05 $-.33 Diluted EPS Revenue $ 20.88M $ 15.19M $ 28.7M Gross Profit $ $ $ Net Income / Loss $ -15.59M $ -11.99M $ -66.95M Operating Income / Loss $ -14.94M $ -11.49M $ -66.29M Cost of Revenue $ $ $ Net Cash Flow $ 3.47M $ 3.19M $ -9.53M PE Ratio     Splits Feb 14, 2018:   1:11 Nov 09, 2012:   1:6